| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 122.558 | 78 |
| GSM780708 | Untreated after 4 days (C2_1) | 138.475 | 79 |
| GSM780709 | Untreated after 4 days (C3_1) | 118.332 | 78 |
| GSM780719 | Untreated after 4 days (C1_2) | 115.057 | 77 |
| GSM780720 | Untreated after 4 days (C2_2) | 147.977 | 80 |
| GSM780721 | Untreated after 4 days (C3_2) | 137.356 | 79 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 144.634 | 80 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 128.402 | 79 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 135.458 | 79 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 129.058 | 79 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 161.051 | 81 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 138.616 | 79 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 119.711 | 78 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 127.185 | 78 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 136.464 | 79 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 147.548 | 80 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 134.293 | 79 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 128.831 | 79 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 218.142 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 176.196 | 82 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 141.265 | 80 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 201.016 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 178.225 | 82 |